Appropriate mineralocorticoid receptor antagonism and salt restriction are essential for primary aldosteronism therapy

被引：1
|
作者：
Sawami, Kosuke [1 ,2 ]
Tanaka, Atsushi [2 ]
Node, Koichi [2 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan
[2] Saga Univ, Dept Cardiovasc Med, Saga, Japan
来源：
HYPERTENSION RESEARCH | 2023年 / 46卷 / 03期
关键词：
Primary aldosteronism; Mineralocorticoid receptor antagonism; Salt restriction;
D O I：
10.1038/s41440-022-01155-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [21] Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels
    Yuichi Yoshida
    Rika Fujiki
    Mizuki Kinoshita
    Kentaro Sada
    Shotaro Miyamoto
    Yoshinori Ozeki
    Yumi Mori
    Naoki Matsuda
    Takaaki Noguchi
    Hiroshi Nakama
    Mitsuhiro Okamoto
    Koro Gotoh
    Takayuki Masaki
    Hirotaka Shibata
    Hypertension Research, 2023, 46 : 100 - 107
  • [22] Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
    Sechi, L. A.
    Colussi, G. L.
    Novello, M.
    Uzzau, A.
    Catena, C.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (13) : 1000 - 1006
  • [23] MINERALOCORTICOID RECEPTOR ANTAGONISTS IMPROVE QUALITY OF LIFE IN PATIENTS WITH PRIMARY ALDOSTERONISM
    Imaishi, Nao
    Yoshida, Yuichi
    Shibuta, Kanako
    Miyamoto, Shotaro
    Ozeki, Yoshinori
    Okamoto, Mitsuhiro
    Gotoh, Koro
    Masaki, Takayuki
    Shibata, Hirotaka
    JOURNAL OF HYPERTENSION, 2023, 41 : E121 - E121
  • [24] MINERALOCORTICOID RECEPTOR ANTAGONISTS DECREASE THE RATES OF POSITIVE SCREENING FOR PRIMARY ALDOSTERONISM
    Tezuka, Yuta
    Turcu, Adina F.
    ENDOCRINE PRACTICE, 2020, 26 (12) : 1416 - 1424
  • [25] Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
    Tezuka, Yuta
    Turcu, Adina F.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design
    Giacomo Rossitto
    Maurizio Cesari
    Giulio Ceolotto
    Giuseppe Maiolino
    Teresa Maria Seccia
    Gian Paolo Rossi
    Journal of Human Hypertension, 2019, 33 : 167 - 171
  • [27] Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era
    Catena, Cristiana
    Colussi, GianLuca
    Sechi, Leonardo A.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (01) : C1 - C5
  • [28] Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism
    Pecori, Alessio
    Buffolo, Fabrizio
    Burrello, Jacopo
    Mengozzi, Giulio
    Rumbolo, Francesca
    Avataneo, Valeria
    D'Avolio, Antonio
    Rabbia, Franco
    Bertello, Chiara
    Veglio, Franco
    Mulatero, Paolo
    Monticone, Silvia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3655 - E3664
  • [29] EFFECTS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS ON ALDOSTERONE TO RENIN RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM
    Pecori, Alessio
    Buffolo, Fabrizio
    Burrello, Jacopo
    Mengozzi, Giulio
    Rumbolo, Francesca
    Avataneo, Valeria
    D'Avolio, Antonio
    Rabbia, Franco
    Bertello, Chiara
    Veglio, Franco
    Mulatero, Paolo
    Monticone, Silvia
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E200 - E201
  • [30] AORTIC DILATATION IN PATIENTS WITH PRIMARY ALDOSTERONISM AFTER THERAPY WITH MINERALOCORTICOID RECEPTORS ANTAGONISTS
    Catena, C.
    Colussi, G. L.
    Capobianco, F.
    Russo, A.
    Sechi, L. A.
    JOURNAL OF HYPERTENSION, 2015, 33 : E216 - E216
12345